Investors

NEW YORK, NY, September 11, 2025 - Royalty Pharma plc will host an Investor Day in New York City today. Senior executives will provide an update on the company’s plans to drive shareholder value creation through its unique business model and capabilities in the large and growing market for funding biopharma innovation with royalties.

NEW YORK, NY, September 10, 2025 – Royalty Pharma plc today announced the release of a biopharma royalty market study conducted by Deloitte.

NEW YORK, NY, September 4, 2025 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025 at 3:20 p.m. ET.

NEW YORK, NY, September 2, 2025 – Royalty Pharma plc (Nasdaq: RPRX) announced today that it has priced an offering of $2.0 billion of senior unsecured notes, comprised of the following (collectively, the “Notes”)...